𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intensive chemotherapy in patients with generalized Burkitt's lymphoma

✍ Scribed by John L. Ziegler; Avrum Z. Bluming; Ian T. Magrath; Paul P. Carbone


Publisher
John Wiley and Sons
Year
1972
Tongue
French
Weight
520 KB
Volume
10
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The results of a clinical trial in patients with generalized Burkitt's lymphoma using either multiple doses of cyclophosphamide or a cyclic, sequential regimen employing cylophosphamide, vincristine, methotrexate, and cytosine arabinoside (TRIKE) are reported. Of 42 evaluable patients 24 received cyclophosphamide and 18 received TRIKE. No significant differences were encountered between either group with respect to remission induction, relapse rate or survival. Remission duration was significantly prolonged in the patients receiving cyclophosphamide, but this event has little effect on survival. Although intensive chemotherapy is probably necessary in patients with generalized Burkitt's lymphoma, other variables such as meningeal involvement and immunologic factors appear to affect relapse and survival.


πŸ“œ SIMILAR VOLUMES


Cellular reactions against Burkitt lymph
✍ John F. Hewetson; Sidney H. Golub; George Klein; Surjit Singh πŸ“‚ Article πŸ“… 1972 πŸ› John Wiley and Sons 🌐 French βš– 577 KB

## Abstract A micro‐assay colony inhibition (CI) test has been developed for studying cell‐mediated reactions against lymphoblastoid target cells. The assay makes use of the ability of the target cells, but not the effector cells, to grow in discrete colonies in semi‐solid medium. Peripheral blood

Burkitt's lymphoma in Ghana: Clinical fe
✍ Francis K. Nkrumah; Ida V. Perkins πŸ“‚ Article πŸ“… 1973 πŸ› John Wiley and Sons 🌐 French βš– 694 KB

## Abstract The clinical presentation, response to chemotherapy, relapse pattern and prognosis in Burkitt's lymphoma were evaluated in a prospective manner in 54 patients. Cyclophosphamide induced complete clinical remission in over 75% of the patients irrespective of stage of the disease. Long‐ter